Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) Director Sells $47,076.40 in Stock

Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) Director Stephen P. Mawer sold 3,655 shares of the company’s stock in a transaction dated Monday, March 24th. The shares were sold at an average price of $12.88, for a total value of $47,076.40. Following the completion of the sale, the director now owns 287,307 shares in the company, valued at $3,700,514.16. This trade represents a 1.26 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Calumet Specialty Products Partners Stock Down 2.2 %

Calumet Specialty Products Partners stock opened at $13.16 on Friday. The company has a market capitalization of $1.13 billion, a PE ratio of -4.77 and a beta of 1.88. Calumet Specialty Products Partners, L.P. has a 12-month low of $9.97 and a 12-month high of $25.29. The firm’s fifty day moving average is $14.72 and its 200 day moving average is $18.45.

Calumet Specialty Products Partners (NASDAQ:CLMT) last announced its quarterly earnings data on Friday, February 28th. The oil and gas company reported ($0.47) earnings per share for the quarter, beating the consensus estimate of ($1.06) by $0.59. The company had revenue of $949.50 million for the quarter, compared to analyst estimates of $921.76 million. Calumet Specialty Products Partners’s revenue for the quarter was down 2.8% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.59) EPS. Sell-side analysts expect that Calumet Specialty Products Partners, L.P. will post -3.02 EPS for the current fiscal year.

Analyst Ratings Changes

Several analysts recently commented on the company. Wells Fargo & Company reduced their target price on Calumet Specialty Products Partners from $29.00 to $28.00 and set an “overweight” rating on the stock in a report on Wednesday, March 5th. HC Wainwright reiterated a “buy” rating and set a $33.00 price objective on shares of Calumet Specialty Products Partners in a research report on Monday, March 3rd. TD Cowen lowered shares of Calumet Specialty Products Partners from a “buy” rating to a “hold” rating and dropped their target price for the company from $26.00 to $16.00 in a report on Tuesday, March 4th. Finally, UBS Group upgraded Calumet Specialty Products Partners from a “sell” rating to a “neutral” rating and decreased their price target for the stock from $15.00 to $12.00 in a report on Monday, March 17th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $20.80.

Calumet Specialty Products Partners Company Profile

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.